200 related articles for article (PubMed ID: 12112400)
1. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
Roberts RC; Force M; Kung L
Synapse; 2002 Aug; 45(2):78-85. PubMed ID: 12112400
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic olanzapine treatment on striatal synaptic organization.
Roberts RC
Synapse; 2001 Jan; 39(1):8-15. PubMed ID: 11071704
[TBL] [Abstract][Full Text] [Related]
4. Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
Hattori T; Takada M; Moriizumi T; Van der Kooy D
J Comp Neurol; 1991 Jul; 309(3):391-401. PubMed ID: 1717519
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic haloperidol treatment on dendritic spines in the rat striatum.
Kelley JJ; Gao XM; Tamminga CA; Roberts RC
Exp Neurol; 1997 Aug; 146(2):471-8. PubMed ID: 9270058
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rats: a study of unlabeled and enkephalin-labeled striatal terminals.
Roberts RC; Lapidus B
J Neural Transm (Vienna); 2003 Sep; 110(9):961-75. PubMed ID: 12938022
[TBL] [Abstract][Full Text] [Related]
7. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
8. Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations.
Soiza-Reilly M; Azcurra JM
Neurotoxicol Teratol; 2009; 31(4):191-7. PubMed ID: 19336253
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment.
Zhang Y; Xu H; He J; Yan B; Jiang W; Li X; Li XM
Neurosci Lett; 2007 Jun; 420(1):66-71. PubMed ID: 17466452
[TBL] [Abstract][Full Text] [Related]
10. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats.
See RE; Chapman MA; Meshul CK
Synapse; 1992 Oct; 12(2):147-54. PubMed ID: 1362290
[TBL] [Abstract][Full Text] [Related]
11. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Kulkarni SK; Bishnoi M; Chopra K
Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
[TBL] [Abstract][Full Text] [Related]
12. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
13. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Lee J; Rushlow WJ; Rajakumar N
Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
[TBL] [Abstract][Full Text] [Related]
14. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term administration of haloperidol on electrophysiologic properties of rat mesencephalic neurons.
Gariano RF; Young SJ; Jeste DV; Segal DS; Groves PM
J Pharmacol Exp Ther; 1990 Oct; 255(1):108-13. PubMed ID: 2213545
[TBL] [Abstract][Full Text] [Related]
16. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
[TBL] [Abstract][Full Text] [Related]
18. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
Mahadik SP; Mukherjee S
Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
20. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
Dlaboga D; Hajjhussein H; O'Donnell JM
Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
